Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 8월 20

Fresenius Medical Care AG

FMSNYSE
Trade with Public
Trade with Public
$23.84
0.281.19%
가까이에: Aug 19, 5:00 PM EST
$23.84
N/A
시간외: 4:38 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

Fresenius Medical Care Financials

Fresenius Medical Care (FMS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.
Benzinga Newsdesk

PRO
Fresenius Medical Care Q2 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $5.651B Miss $5.720B Estimate

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 26.92 percent increase over earnings of $0.52 per share from
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.870B Est

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.870 billion estimate.
Benzinga Newsdesk

PRO
Fresenius Medical Care Q1 Adj. EPS $0.53 Misses $0.59 Estimate, Sales $5.401B Miss $5.720B Estimate

Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 percent. This is a 20.45 percent increase over earnings of $0.44 per share
Benzinga Newsdesk

PRO
Fresenius Medical Care Sees FY2026 Sales $23.764B vs $22.640B Est

Fresenius Medical Care (NYSE:FMS) sees FY2026 sales of $23.764 billion vs $22.640 billion analyst estimate.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved